Lipophilicity and Transporter Influence on Blood-retinal Barrier Permeability: a Comparison with Blood-brain Barrier Permeability

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2010 Sep 23

PMID 20859661

Citations 14

Authors

Ken-Ichi Hosoya

Atsushi Yamamoto

Shin-Ichi Akanuma

Masanori Tachikawa

Affiliations

Soon will be listed here.

Abstract

Purpose: To determine the lipophilicity trend line from the relationship between the blood-retinal barrier (BRB) permeability and the lipophilicity of permeants and compare it with that of the blood-brain barrier (BBB).

Methods: The retinal (RUI) and brain uptake index (BUI) of 26 radiolabeled compounds across the rat BRB and BBB, respectively, were measured using the carotid artery injection method.

Results: RUI was determined using 13 compounds expected to be transported from blood to the retina by passive diffusion and with a log n-octanol/Ringer distribution coefficient (DC) ranging from -2.56 to 2.48. The RUI values were correlated with the log of the DC [RUI = 46.2 × exp (0.515 × log DC), r(2) = 0.807]. A similar trend was obtained between BUI and lipophilicity. The RUI value for substrates of the influx transporters and P-glycoprotein (P-gp) was greater and smaller than the lipophilicity trend line, respectively. In contrast, [(3)H]verapamil, which is a substrate of P-gp, has a greater RUI value than the lipophilicity trend line, but not for BUI, suggesting that the BRB has an influx transport system for verapamil.

Conclusions: The lipophilicity trend line constructed from the RUI and DC values is considered to reflect the transport properties of drugs undergoing passive diffusion across the BRB.

Citing Articles

Application of in silico methods to predict the acute toxicity of bicyclic organophosphorus compounds as potential chemical weapon.

Noga M, Jurowski K Arch Toxicol. 2025; .

PMID: 40050428 DOI: 10.1007/s00204-025-04000-8.

Lipopolysaccharide-Induced Functional Alteration of P-glycoprotein in the Ex Vivo Rat Inner Blood-Retinal Barrier.

Daikohara K, Akanuma S, Kubo Y, Hosoya K Int J Mol Sci. 2022; 23(24).

PMID: 36555148 PMC: 9779076. DOI: 10.3390/ijms232415504.

Bile Duct Ligation Impairs Function and Expression of Mrp1 at Rat Blood-Retinal Barrier via Bilirubin-Induced P38 MAPK Pathway Activations.

Li P, Yang Y, Lin Z, Hong S, Jiang L, Zhou H Int J Mol Sci. 2022; 23(14).

PMID: 35887010 PMC: 9318728. DOI: 10.3390/ijms23147666.

Biological Membrane-Penetrating Peptides: Computational Prediction and Applications.

de Oliveira E, Costa K, Taube P, Lima A, de Sales Junior C Front Cell Infect Microbiol. 2022; 12:838259.

PMID: 35402305 PMC: 8992797. DOI: 10.3389/fcimb.2022.838259.

Comprehensive Evidence of Carrier-Mediated Distribution of Amantadine to the Retina across the Blood-Retinal Barrier in Rats.

Shinozaki Y, Akanuma S, Mori Y, Kubo Y, Hosoya K Pharmaceutics. 2021; 13(9).

PMID: 34575415 PMC: 8469395. DOI: 10.3390/pharmaceutics13091339.

References

Boado R, Li J, Nagaya M, Zhang C, Pardridge W . Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci U S A. 1999; 96(21):12079-84. PMC: 18415. DOI: 10.1073/pnas.96.21.12079. View

Sugiyama D, Kusuhara H, Taniguchi H, Ishikawa S, Nozaki Y, Aburatani H . Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine. J Biol Chem. 2003; 278(44):43489-95. DOI: 10.1074/jbc.M306933200. View

Tsuji A, Terasaki T, Takabatake Y, Tenda Y, Tamai I, Yamashima T . P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. Life Sci. 1992; 51(18):1427-37. DOI: 10.1016/0024-3205(92)90537-y. View

Tomi M, Mori M, Tachikawa M, Katayama K, Terasaki T, Hosoya K . L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier. Invest Ophthalmol Vis Sci. 2005; 46(7):2522-30. DOI: 10.1167/iovs.04-1175. View

Stoll J, Wadhwani K, Smith Q . Identification of the cationic amino acid transporter (System y+) of the rat blood-brain barrier. J Neurochem. 1993; 60(5):1956-9. DOI: 10.1111/j.1471-4159.1993.tb13428.x. View

Tomi M, Kitade N, Hirose S, Yokota N, Akanuma S, Tachikawa M . Cationic amino acid transporter 1-mediated L-arginine transport at the inner blood-retinal barrier. J Neurochem. 2009; 111(3):716-25. DOI: 10.1111/j.1471-4159.2009.06367.x. View

Cunha-Vaz J . The blood-retinal barriers system. Basic concepts and clinical evaluation. Exp Eye Res. 2004; 78(3):715-21. DOI: 10.1016/s0014-4835(03)00213-6. View

Asashima T, Hori S, Ohtsuki S, Tachikawa M, Watanabe M, Mukai C . ATP-binding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells. Pharm Res. 2006; 23(6):1235-42. DOI: 10.1007/s11095-006-0067-2. View

Tornquist P, Alm A . Carrier-mediated transport of amino acids through the blood-retinal and the blood-brain barriers. Graefes Arch Clin Exp Ophthalmol. 1986; 224(1):21-5. DOI: 10.1007/BF02144127. View

10.

Pardridge W, Mietus L, Frumar A, Davidson B, Judd H . Effects of human serum on transport of testosterone and estradiol into rat brain. Am J Physiol. 1980; 239(1):E103-8. DOI: 10.1152/ajpendo.1980.239.1.E103. View

11.

Tagami M, Kusuhara S, Honda S, Tsukahara Y, Negi A . Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy. Brain Res. 2009; 1283:186-93. DOI: 10.1016/j.brainres.2009.05.095. View

12.

Isakovic A, Abbott N, Redzic Z . Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat. J Neurochem. 2004; 90(2):272-86. DOI: 10.1111/j.1471-4159.2004.02439.x. View

13.

Ohkura Y, Akanuma S, Tachikawa M, Hosoya K . Blood-to-retina transport of biotin via Na+-dependent multivitamin transporter (SMVT) at the inner blood-retinal barrier. Exp Eye Res. 2010; 91(3):387-92. DOI: 10.1016/j.exer.2010.06.010. View

14.

Clarke G, OMahony S, Cryan J, Dinan T . Verapamil in treatment resistant depression: a role for the P-glycoprotein transporter?. Hum Psychopharmacol. 2009; 24(3):217-23. DOI: 10.1002/hup.1008. View

15.

Smeets P, van Aubel R, Wouterse A, van den Heuvel J, Russel F . Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter. J Am Soc Nephrol. 2004; 15(11):2828-35. DOI: 10.1097/01.ASN.0000143473.64430.AC. View

16.

Leggas M, Adachi M, Scheffer G, Sun D, Wielinga P, Du G . Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol. 2004; 24(17):7612-21. PMC: 506999. DOI: 10.1128/MCB.24.17.7612-7621.2004. View

17.

Alm A, Tornquist P . The uptake index method applied to studies on the blood-retinal barrier. I. A methodological study. Acta Physiol Scand. 1981; 113(1):73-9. DOI: 10.1111/j.1748-1716.1981.tb06864.x. View

18.

Han Y, Sweet D, Hu D, Pritchard J . Characterization of a novel cationic drug transporter in human retinal pigment epithelial cells. J Pharmacol Exp Ther. 2001; 296(2):450-7. View

19.

Bleeker G, van Haeringen N, MAAS E, GLASIUS E . Selective properties of the vitreous barrier. Exp Eye Res. 1968; 7(1):37-46. DOI: 10.1016/s0014-4835(68)80024-7. View

20.

Puchowicz M, Xu K, Magness D, Miller C, Lust W, Kern T . Comparison of glucose influx and blood flow in retina and brain of diabetic rats. J Cereb Blood Flow Metab. 2004; 24(4):449-57. DOI: 10.1097/00004647-200404000-00010. View